403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
U.S. Senate Votes to End Democratic Filibuster, Push Funding Bill
(MENAFN) The U.S. Senate delivered a pivotal procedural breakthrough Sunday, securing a 60-40 vote to overcome Democratic opposition and propel government funding legislation forward—a critical advancement toward ending America's five-week federal shutdown.
Eight Democratic senators crossed party lines to join Republican colleagues in supporting the measure, which guarantees future consideration of Affordable Care Act (ACA) subsidy extensions and mandates rehiring federal workers terminated during the closure.
Democratic Whip Dick Durbin defied party leadership by endorsing the compromise, alongside Democratic Sens. Catherine Cortez Masto, John Fetterman, Maggie Hassan, Jeanne Shaheen, Tim Kaine and Jacky Rosen and independent Sen. Angus King.
Republican Sen. Rand Paul stood alone as the sole GOP dissenter.
The positive momentum emerged amid widespread reports indicating bipartisan negotiators secured a framework funding federal operations through January's conclusion, contingent upon Senate Republican guarantees to address healthcare subsidies expiring Jan. 1.
Final approval remains uncertain, however, as individual senators retain procedural authority to delay proceedings for multiple days under chamber regulations.
The House of Representatives must also reconvene and ratify the Senate agreement before transmission to President Donald Trump for executive authorization.
Floor tensions escalated momentarily when four Republican senators—John Cornyn, Rick Scott, Mike Lee and Ron Johnson—temporarily withheld their support.
Cornyn reached the Capitol behind schedule, while the remaining trio engaged in discussions with Senate Majority Leader John Thune and Senate Finance Committee Chairman Mike Crapo before ultimately casting affirmative votes.
Post-vote, Johnson disclosed to reporters only that they had "issues" to discuss, without elaborating.
The Senate anticipates conducting a conclusive funding bill vote within days, potentially terminating one of America's most protracted government shutdowns in recent history.
Eight Democratic senators crossed party lines to join Republican colleagues in supporting the measure, which guarantees future consideration of Affordable Care Act (ACA) subsidy extensions and mandates rehiring federal workers terminated during the closure.
Democratic Whip Dick Durbin defied party leadership by endorsing the compromise, alongside Democratic Sens. Catherine Cortez Masto, John Fetterman, Maggie Hassan, Jeanne Shaheen, Tim Kaine and Jacky Rosen and independent Sen. Angus King.
Republican Sen. Rand Paul stood alone as the sole GOP dissenter.
The positive momentum emerged amid widespread reports indicating bipartisan negotiators secured a framework funding federal operations through January's conclusion, contingent upon Senate Republican guarantees to address healthcare subsidies expiring Jan. 1.
Final approval remains uncertain, however, as individual senators retain procedural authority to delay proceedings for multiple days under chamber regulations.
The House of Representatives must also reconvene and ratify the Senate agreement before transmission to President Donald Trump for executive authorization.
Floor tensions escalated momentarily when four Republican senators—John Cornyn, Rick Scott, Mike Lee and Ron Johnson—temporarily withheld their support.
Cornyn reached the Capitol behind schedule, while the remaining trio engaged in discussions with Senate Majority Leader John Thune and Senate Finance Committee Chairman Mike Crapo before ultimately casting affirmative votes.
Post-vote, Johnson disclosed to reporters only that they had "issues" to discuss, without elaborating.
The Senate anticipates conducting a conclusive funding bill vote within days, potentially terminating one of America's most protracted government shutdowns in recent history.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment